acetazolamide has been researched along with Tricuspid Incompetence in 1 studies
Acetazolamide: One of the CARBONIC ANHYDRASE INHIBITORS that is sometimes effective against absence seizures. It is sometimes useful also as an adjunct in the treatment of tonic-clonic, myoclonic, and atonic seizures, particularly in women whose seizures occur or are exacerbated at specific times in the menstrual cycle. However, its usefulness is transient often because of rapid development of tolerance. Its antiepileptic effect may be due to its inhibitory effect on brain carbonic anhydrase, which leads to an increased transneuronal chloride gradient, increased chloride current, and increased inhibition. (From Smith and Reynard, Textbook of Pharmacology, 1991, p337)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Richalet, JP | 1 |
| Rivera-Ch, M | 1 |
| Maignan, M | 1 |
| Privat, C | 1 |
| Pham, I | 1 |
| Macarlupu, JL | 1 |
| Petitjean, O | 1 |
| León-Velarde, F | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Hypoventilation and High Altitude Chronic Polycythemia: Acetazolamide as a Possible Treatment[NCT00424970] | Phase 4 | 55 participants (Anticipated) | Interventional | 2007-01-31 | Completed | ||
| Randomized Controlled Trial of N-acetylcysteine and Acetazolamide in Treatment of Chronic Mountain Sickness[NCT01187108] | Phase 1/Phase 2 | 85 participants (Actual) | Interventional | 2013-06-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for acetazolamide and Tricuspid Incompetence
| Article | Year |
|---|---|
Acetazolamide for Monge's disease: efficiency and tolerance of 6-month treatment.
Topics: Acetazolamide; Altitude Sickness; Analysis of Variance; Carbonic Anhydrase Inhibitors; Cardiac Outpu | 2008 |
Acetazolamide for Monge's disease: efficiency and tolerance of 6-month treatment.
Topics: Acetazolamide; Altitude Sickness; Analysis of Variance; Carbonic Anhydrase Inhibitors; Cardiac Outpu | 2008 |
Acetazolamide for Monge's disease: efficiency and tolerance of 6-month treatment.
Topics: Acetazolamide; Altitude Sickness; Analysis of Variance; Carbonic Anhydrase Inhibitors; Cardiac Outpu | 2008 |
Acetazolamide for Monge's disease: efficiency and tolerance of 6-month treatment.
Topics: Acetazolamide; Altitude Sickness; Analysis of Variance; Carbonic Anhydrase Inhibitors; Cardiac Outpu | 2008 |